News

Boeckh and Hill
Dr. Hill (right) with Dr. Michael Boeckh discussing a co-authored study. Photo by Robert Hood / Fred Hutch News Service
Hill at podium
Dr. Hill speaking on infections following CAR T cell therapy at the 2nd Symposium on Infectious Diseases in the Immunocompromised Host, June 19, 2017 in Seattle, WA. Photo by Robert Hood / Fred Hutch News Service

A podcast and radio broadcast with Dr. Joshua Hill on his research into infection risk in cancer patients treated with CD19-targeted CAR-T therapy

The Onco’Zine Brief on PRX | Mar 3, 2018
In this interview, Dr. Hill discusses the promise and perils of CD19-targeted CAR-T cell therapy.

Dr. Joshua Hill receives Amy Strelzer Manasevit Research Program grant

Hutch News | Mary Engel | June 6, 2018
Award will help fund 'paradigm shift' in diagnosing post-transplant infections.

First systematic study of infections after CAR T-cell therapy

Hutch News | Susan Keown | Nov. 6, 2017
"Benchmark" research could help reduce complications of emerging immunotherapy

Dr. Joshua Hill wins the HHV-6 Foundation Caroline B. Hall Young Investigator Award

HHV-6 Foundation website | Jan. 15, 2016
Dr. Hill is recognized for his work on projects including the use of a reverse transcription PCR test to identify HHV-6 infections in pulmonary disease and pneumonia after transplantation.

Dr. Joshua Hill receives NIH career development award

HHV-6 Foundation website | June 30, 2015
The K23 grant from the National Institute of Allergy and Infectious Diseases will support Dr. Hill's committed efforts to advance understanding of diseases associated with HHV-6 in hematopoietic cell transplant recipients.

Interview with Michael Boeckh and Joshua Hill on potential risks for ciHHV6 patients undergoing HCT

HHV-6 Foundation website | Sep. 30, 2014
Drs. Boeckh and Hill discuss important considerations for treatment of transplant patients.